FDA Warns of Increased Lymphoma Risk From Breast Implants

On Feb. 6, the FDA issued an update on the number of cases of breast implant-associated anaplastic large cell lymphoma, reporting that as of Sept. 30, 2018, the agency had received a total of 660 global reports regarding cases since 2010.
Source: AAFP News - Category: Primary Care Source Type: news